David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
